Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 3
2013 11
2014 21
2015 25
2016 15
2017 17
2018 16
2019 29
2020 27
2021 37
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy toxicity.
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. De Ruysscher D, et al. Among authors: siva s. Nat Rev Dis Primers. 2019 Feb 21;5(1):13. doi: 10.1038/s41572-019-0064-5. Nat Rev Dis Primers. 2019. PMID: 30792503 Review.
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis.
Sathianathen NJ, Koschel S, Thangasamy IA, Teh J, Alghazo O, Butcher G, Howard H, Kapoor J, Lawrentschuk N, Siva S, Azad A, Tran B, Bolton D, Murphy DG. Sathianathen NJ, et al. Among authors: siva s. Eur Urol. 2020 Mar;77(3):365-372. doi: 10.1016/j.eururo.2019.09.004. Epub 2019 Nov 1. Eur Urol. 2020. PMID: 31679970
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A, Myrehaug SD, Siva S, Masucci GL, Maralani PJ, Brundage M, Butler J, Chow E, Fehlings MG, Foote M, Gabos Z, Greenspoon J, Kerba M, Lee Y, Liu M, Liu SK, Thibault I, Wong RK, Hum M, Ding K, Parulekar WR; trial investigators. Sahgal A, et al. Among authors: siva s. Lancet Oncol. 2021 Jul;22(7):1023-1033. doi: 10.1016/S1470-2045(21)00196-0. Epub 2021 Jun 11. Lancet Oncol. 2021. PMID: 34126044 Clinical Trial.
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
Siva S, Bressel M, Mai T, Le H, Vinod S, de Silva H, Macdonald S, Skala M, Hardcastle N, Rezo A, Pryor D, Gill S, Higgs B, Wagenfuehr K, Montgomery R, Awad R, Chesson B, Eade T, Wong W, Sasso G, De Abreu Lourenco R, Kron T, Ball D, Neeson P; Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators. Siva S, et al. JAMA Oncol. 2021 Oct 1;7(10):1476-1485. doi: 10.1001/jamaoncol.2021.2939. JAMA Oncol. 2021. PMID: 34455431 Clinical Trial.
Lung Cancer in Australia.
John T, Cooper WA, Wright G, Siva S, Solomon B, Marshall HM, Fong KM. John T, et al. Among authors: siva s. J Thorac Oncol. 2020 Dec;15(12):1809-1814. doi: 10.1016/j.jtho.2020.09.005. J Thorac Oncol. 2020. PMID: 33246594 Free article. No abstract available.
Radiation is not the Ideal Solution.
Siva S, Steinfort DP. Siva S, et al. Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):7-8. doi: 10.1016/j.ijrobp.2019.11.409. Int J Radiat Oncol Biol Phys. 2021. PMID: 33308705 No abstract available.
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M. Siva S, et al. Cancer. 2018 Mar 1;124(5):934-942. doi: 10.1002/cncr.31156. Epub 2017 Dec 20. Cancer. 2018. PMID: 29266183 Free article.
The Epidemiology of Lung Metastases.
Chen H, Stoltzfus KC, Lehrer EJ, Horn SR, Siva S, Trifiletti DM, Meng MB, Verma V, Louie AV, Zaorsky NG. Chen H, et al. Among authors: siva s. Front Med (Lausanne). 2021 Sep 20;8:723396. doi: 10.3389/fmed.2021.723396. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34616754 Free PMC article.
196 results